Latest FDA Stories
TARRYTOWN, N.Y. and PARIS, Jan. 26, 2015 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi today announced that the U.S.
The U.S. Supreme Court has denied a petition submitted by Teva Pharmaceuticals USA Inc. in which the generic drug maker sought to challenge a lawsuit brought over generic drug injuries.
CDRH broke its own device warning letter record in 2013 and experts predict that trend will continue in 2015.
DUBLIN, Jan. 23, 2015 /PRNewswire/ -- Shire plc (LSE: SHP, NASDAQ: SHPG) notes the announcement today by NPS Pharmaceuticals, Inc. (NASDAQ: NPSP) that the U.S.
With today's approval, Bexsero is now licensed in 37 countries; since first approval in Europe, over 1 million doses have been distributed worldwide BASEL, Switzerland, Jan.
ORLANDO, Fla. and DUBLIN, Jan. 23, 2015 /PRNewswire/ -- Immune Therapeutics, Inc. today announced the signing of the agreement with KRS Global Biotechnology, Inc.
Although recently approved by the FDA, the potential effectiveness of the new Maestro implantable weight loss surgery device leaves questions in the minds of many, leading people to take a second
NORTHBROOK, Ill., Jan. 22, 2015 /PRNewswire/ -- Astellas today announced that the U.S.
Funds to Advance Novel Biologic Pipeline and Internal Operations SHANGHAI, Jan.
Only FDA-approved and only Pregnancy Category A prescription treatment for Nausea and Vomiting of Pregnancy is now available in Texas through the state-administered Medicaid Drug Rebate Program
- In the month which preceded the present; in the last month, as distinguished from the current or present month and all others.